WNT4 and breast cancer: Accordingly, WNT4 dysfunction is associated with reproductive, gynecologic, and endocrine pathologies including precancerous uterine lesions, ovarian cancer, and the breast cancer subtype invasive lobular carcinoma (ILC; reviewed in ref. 1).